PRA's Feasibility group provides comprehensive feasibility assessments for clinical trials and drug development programs. We have an excellent track record of success saving sponsors countless hours and expense through the strategic use of our feasibility results. From small changes to protocols to adjustment of site locations and/or accrual rates, our feasibility team can help. The feasibility team prides itself on being able to provide rapid and accurate feedback on protocols, enabling sponsors to adjust their study parameters from the outset and better position studies for successful enrolment.
Our Feasibility group works with Investigator Relations, Medical Affairs, Scientific Affairs and Regulatory Affairs to distribute and collate confidentiality agreements and feasibility questionnaires at all levels.
A feasibility study provides investigator feedback on the following:
- Regional standards of care
- Ethical or cultural issues
- Feedback concerning the protocol design
- Competing studies
- Potential regulatory issues
- Patient availability
- Investigator and site experience
- Overall study interest